Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease

Thumbnail
Fulltext:
217350.pdf
Size:
284.2Kb
Format:
PDF
Description:
publisher's version
Download
Publication year
2020
Author(s)
Dankers, M.
Nelissen-Vrancken, Marjorie H.J.M.G.
Surminski, Sara M.K.
Lambooij, Anke C.
Schermer, T.R.J.
Dijk, C.E.M.J. van
Source
Frontiers in Pharmacology, 10, (2020), article 1519
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/217350   https://hdl.handle.net/2066/217350
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.